Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Jan 2006

Hsiao Liang-Tsai, Chiou Tzeon-Jye, Liu Jin-Hwang, Chu Chiau-Jun, Lin Yu-Chen, Chao Ta-Chung, Wang Wei-Shu, Yen Chueh-Chuan, Yang Muh-Hwa, Tzeng Cheng-Hwai, Chen Po-Min

Abstract excerpt

Lamivudine has demonstrated efficacy in the treatment and prevention of hepatitis B virus (HBV) reactivation after hematopoietic stem cell transplantation (HSCT). However, most of these studies involved short durations of prophylaxis, so there is significant concern regarding lamivudine resistance in these patients. Between March 1984 and November 2002, 71 HBV surface antigen-positive HSCT recipients, including a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance
Share to Hematologic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Hepatitis B

Share to Hepatitis B virus

Share to Lamivudine

Share to Viral Load

Share to Virus Activation

Source

Identifiers

PMID: 16399572
DOI: 10.1016/j.bbmt.2005.09.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.PMID 16399572Read ↗

Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.Semantic proximity Read ↗

Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Management of hepatitis B after renal transplantation: an update.Semantic proximity Read ↗

Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation.Semantic proximity Read ↗

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants.Semantic proximity Read ↗

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationSemantic proximity Read ↗

Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.Semantic proximity Read ↗

Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis.Semantic proximity Read ↗

Prophylaxis and treatment of hepatitis B recurrence after liver transplantation in the antiviral era.Semantic proximity Read ↗

Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.Semantic proximity Read ↗

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.Semantic proximity Read ↗

Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.